Palforzia Evrópusambandið - íslenska - EMA (European Medicines Agency)

palforzia

aimmune therapeutics ireland limited - defatted powder of arachis hypogaea l., semen (peanuts) - peanut hypersensitivity - allergens - palforzia is indicated for the treatment of patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy. palforzia may be continued in patients 18 years of age and older. palforzia should be used in conjunction with a peanut-avoidant diet.

Genta-Equine Stungulyf, lausn 100 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

genta-equine stungulyf, lausn 100 mg/ml

franklin pharmaceuticals ltd. - gentamicinum súlfat - stungulyf, lausn - 100 mg/ml

Hizentra Evrópusambandið - íslenska - EMA (European Medicines Agency)

hizentra

csl behring gmbh - manna eðlilegt immúnóglóbúlín (scig) - Ónæmisfræðilegir skortsyndar - Ónæmiskerfið sera og mótefni, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.

Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) Evrópusambandið - íslenska - EMA (European Medicines Agency)

pandemic influenza vaccine h5n1 astrazeneca (previously pandemic influenza vaccine h5n1 medimmune)

astrazeneca ab - reassortant inflúensu veira (lifandi, bæklaða) eftir álag: a/víetnam/1203/2004 (h5n1) álag - inflúensu, manna - bóluefni - fyrirbyggjandi inflúensu í opinberlega lýst faraldur ástandið í börn og unglingar frá 12 mánuði til að minna en 18 ára aldri. faraldur inflúensu h5n1 astrazeneca ætti að vera notuð í samræmi við opinbera leiðsögn.

Improvac Evrópusambandið - íslenska - EMA (European Medicines Agency)

improvac

zoetis belgium sa - synthetic peptide analogue of gnrf conjugated to diptheria toxoid - Ónæmissjúkdómar fyrir suidae - male pigs (from 8 weeks of age); female pigs (from 14 weeks of age) - male pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of testicular function. for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. einnig er hægt að minnka annan lykilframlag í söguna, skatole, sem óbein áhrif. Árásargjarn og kynferðisleg (uppbyggjandi) hegðun er einnig minni. female pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of ovarian function (suppression of oestrus) in order to reduce the incidence of unwanted pregnancies in gilts intended for slaughter, and to reduce the associated sexual behaviour (standing oestrus).

Quetiapin Medical Valley Forðatafla 300 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

quetiapin medical valley forðatafla 300 mg

medical valley invest ab - quetiapinum fúmarat - forðatafla - 300 mg

Quetiapin Medical Valley Forðatafla 150 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

quetiapin medical valley forðatafla 150 mg

medical valley invest ab - quetiapinum fúmarat - forðatafla - 150 mg

Quetiapin Medical Valley Forðatafla 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

quetiapin medical valley forðatafla 50 mg

medical valley invest ab - quetiapinum fúmarat - forðatafla - 50 mg

Quetiapin Medical Valley Forðatafla 200 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

quetiapin medical valley forðatafla 200 mg

medical valley invest ab - quetiapinum fúmarat - forðatafla - 200 mg

Quetiapin Medical Valley Forðatafla 400 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

quetiapin medical valley forðatafla 400 mg

medical valley invest ab - quetiapinum fúmarat - forðatafla - 400 mg